Victor Abdow
Pediatrics · Rockville, MDNPI 1306806872
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $44,750 of the $58,312 with a category attached, or 76.7%. Tris Pharma Inc accounts for 86.7% of it on its own, with 23 other manufacturers making up the rest. Among pediatrics clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 398 payments — averaging $146.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tris Pharma Inc$51K
- Corium, LLC$4K
- Supernus Pharmaceuticals, Inc.$612
- Novo Nordisk$590
- Kaleo, Inc.$397
- Merck$367
- plus $2K from 18 others
What the payments were for
- Consulting fees$3,0805%
- Speaking & faculty fees$44,75077%
- Travel & lodging$2,2844%
- Food & beverage$8,15214%
- Education$260%
- Gifts$200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tris Pharma Inc | 164 | $50,553 |
| Corium, LLC | 33 | $3,992 |
| Supernus Pharmaceuticals, Inc. | 47 | $612 |
| Novo Nordisk | 27 | $590 |
| Kaleo, Inc. | 21 | $397 |
| Merck | 14 | $367 |
| Ironshore Pharmaceuticals Inc. | 13 | $294 |
| Adlon Therapeutics L.p. | 17 | $260 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $246 |
| GSK | 5 | $151 |
| Rhythm Pharmaceuticals, Inc. | 4 | $143 |
| Cranial Technologies, Inc | 12 | $132 |
| Tolmar, Inc. | 5 | $106 |
| Sanofi Pasteur Inc. | 4 | $85 |
| Alk-abello, Inc | 3 | $81 |
| AstraZeneca | 3 | $62 |
| Vertical Pharmaceuticals, LLC | 3 | $54 |
| Tolmar Pharmaceuticals, Inc. | 2 | $48 |
| Arbor Pharmaceuticals, Inc. | 3 | $41 |
| Teva Pharmaceuticals USA, Inc. | 2 | $28 |
| Ascendis Pharma Endocrinology Inc | 1 | $23 |
| Neos Therapeutics, LP | 1 | $18 |
| Genentech USA, Inc. | 1 | $16 |
| Pfizer | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Dyanavel XR$48,351
- Quillivant$42,087
- Quillichew ER$41,864
- Azstarys$3,080
- Sogroya$115
- QELBREE$108
How this compares
$58,312 in reported general payments places this provider in the 95th percentile of 1,307 pediatrics providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 16 | $17,784 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 14 | $2,307 |
Paid to pharmacies, not to this prescriber.
Other pediatrics in Rockville
- Hari SachsRockville$114K
- John PierceRockville$47K
- Pengxin LinRockville$7K
- Gul ChablaniRockville$7K
- Jitendrakumar ModiAnnapolis$149K
- Mary Elizabeth YoungerBaltimore$130K
- Brenda BanwellBaltimore$109K
- Ellen FieldsSilver Spring$68K
- John ThomsonBaltimore$67K
- Carmelo CuffariBaltimore$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.